A sophisticated biological negotiation with its host's immune system
In the quiet margins of public health, where small creatures carry enormous consequences, researchers at the University of Tennessee have identified a molecular mechanism by which ticks transmit disease to their hosts. Published in The EMBO Journal, the discovery centers on a glycine-rich protein carried within exosomal particles in tick saliva — structures that help the parasite evade immune detection while delivering pathogens. As tick-borne illnesses expand in range and frequency, this finding offers something rare: a specific biological target that, if blocked, could interrupt transmission before infection takes hold.
- Tick-borne diseases are rising globally, yet the precise molecular machinery enabling transmission has remained poorly understood — leaving prevention strategies blunt and incomplete.
- The discovery that ticks weaponize exosomes — tiny protein-laden vesicles in their saliva — reveals how these parasites conduct a sophisticated biological negotiation with host immune systems, feeding undetected for days while delivering pathogens.
- A single glycine-rich protein has been identified as a linchpin in this process, simultaneously suppressing immune response and facilitating pathogen movement from tick to host.
- Researchers are now pointing toward this protein as a therapeutic target — one that could be blocked through vaccination or drug intervention, interrupting transmission at the molecular level rather than merely at the bite.
- The finding builds on foundational laboratory work dating to 2018, suggesting a broader pattern across arthropod vectors and positioning this discovery as a potential turning point in how vector-borne disease prevention is approached.
Ticks are easy to overlook — small, slow, and largely silent — yet they carry a disproportionate burden of disease across species and continents. Lyme disease, Rocky Mountain spotted fever, Powassan virus, and others collectively represent a growing public health challenge, one that has expanded in geographic reach alongside shifting climates and land use patterns. Researchers at the University of Tennessee College of Veterinary Medicine have spent years trying to understand not just what ticks carry, but how they deliver it so effectively.
Their latest answer, published in The EMBO Journal, centers on exosomes — microscopic, bubble-like particles that cells produce and release as a form of molecular communication. Tick saliva, it turns out, is dense with these structures, and they carry a glycine-rich protein that performs a dual function: suppressing the host's immune response so the tick can feed undetected, while simultaneously facilitating the transfer of pathogens across the biological boundary between parasite and host.
The work was led by professor Hameeda Sultana and postdoctoral fellow Waqas Ahmed, supported by NIH funding and building on earlier research from Sultana's lab that first characterized tick-derived exosomes between 2018 and 2020. That prior work established that both ticks and mosquitoes produce these vesicles, hinting at a shared transmission strategy among arthropod vectors.
What distinguishes the current finding is its precision. Identifying the glycine-rich protein as a central actor in transmission opens a specific avenue for intervention — one that doesn't rely solely on repellents or pesticides, but instead targets the biological conversation that makes infection possible. Whether through a vaccine or a therapeutic compound, blocking this protein could prevent pathogens from crossing between tick and host before disease begins.
The discovery is a beginning rather than a solution, but it is the kind of foundational insight that sometimes precedes genuine breakthroughs. In revealing the mechanism of its own vulnerability, the tick may have offered researchers the foothold they have long been searching for.
Ticks are small enough to go unnoticed on your skin, yet they carry an outsized burden of disease. Every year, across continents and species, these parasites transmit viruses and bacteria that sicken people, livestock, wildlife, and pets. The damage is diffuse and relentless—a public health problem that rarely makes headlines until someone you know gets Lyme disease or Rocky Mountain spotted fever. Researchers at the University of Tennessee College of Veterinary Medicine have been working to understand the mechanics of how ticks accomplish this feat of transmission, and more importantly, how to interrupt it.
In work published recently in The EMBO Journal, a leading venue for molecular biology research, the team identified a specific protein produced by ticks that appears central to their ability to transmit disease. The discovery emerged from years of careful investigation into the biology of tick saliva—a substance far more complex than it initially appears. When a tick feeds, it is not simply drawing blood. It is orchestrating a sophisticated biological negotiation with its host's immune system, using chemical signals to avoid detection while simultaneously delivering pathogens.
The key to this deception lies in structures called exosomes. These are tiny, bubble-like particles that cells naturally produce and release. Think of them as molecular envelopes, each one carrying messages and proteins from one cell to another. Ticks, it turns out, weaponize these structures. Their saliva is loaded with exosomes containing a glycine-rich protein that serves multiple functions at once: it helps the tick feed without triggering an immune response, and it facilitates the movement of disease-causing pathogens from the tick to the host.
The research was led by professor Hameeda Sultana and postdoctoral fellow Waqas Ahmed, working alongside graduate students and faculty collaborators at the university. The National Institutes of Health provided funding. This work builds on earlier discoveries made by Sultana's laboratory between 2018 and 2020, when her team was among the first to identify and characterize exosomes derived from tick saliva and salivary glands. That foundational work revealed that ticks and mosquitoes both produce these vesicles, suggesting a broader pattern in how arthropod vectors transmit disease.
What makes the current finding significant is its specificity. By pinpointing the glycine-rich protein as a critical player in disease transmission, the researchers have identified a potential target for intervention. If that protein could be blocked—either through vaccination, a drug, or some other means—it might be possible to prevent pathogens from moving between ticks and hosts in the first place. This is different from killing ticks or preventing bites, though those approaches remain important. This is about interrupting the biological conversation that allows transmission to occur.
The complexity of what happens during a tick bite cannot be overstated. The saliva contains not just one molecule but a coordinated cocktail of proteins and signals. Some help the tick pierce skin and access blood vessels. Others suppress inflammation and clotting. Still others actively suppress the host's immune response, allowing the tick to feed for days without being noticed or rejected. Woven through all of this are the exosomes, carrying their own cargo of arthropod proteins that may assist in pathogen acquisition and transmission. Understanding each component is essential to finding weak points in the system.
The implications extend beyond basic science. Tick-borne diseases are increasing in prevalence and geographic range, driven by climate change, land use patterns, and wildlife movement. Lyme disease alone affects hundreds of thousands of people annually in North America and Europe. Rocky Mountain spotted fever, Powassan virus, babesiosis, and anaplasmosis round out a growing list of threats. For livestock and wildlife, the burden is even heavier. A new tool—a way to block transmission at the molecular level—could reshape how we approach vector control and disease prevention.
What happens next depends on whether this protein can be successfully targeted in practice. The discovery is a beginning, not an endpoint. But it represents the kind of fundamental understanding that sometimes precedes real-world solutions. The tick, for all its evolutionary success as a disease vector, may have revealed the mechanism of its own vulnerability.
Notable Quotes
When a tick bites its host, the interaction is more complex than it may appear. Tick saliva contains exosomes filled with a sophisticated cocktail of molecules, allowing them to feed undetected while avoiding triggering the host's immune defenses.— Hameeda Sultana, Professor, University of Tennessee College of Veterinary Medicine
The Hearth Conversation Another angle on the story
So ticks have been transmitting disease for thousands of years. What changed that made this discovery possible now?
The tools changed. We can now see and isolate exosomes—these tiny particles—in ways we couldn't before. Sultana's team developed methods to extract and study them. Once you can see the mechanism, you can ask: what if we block it?
And this glycine-rich protein is the linchpin?
It appears to be one of them. It's not the only molecule in tick saliva doing work, but it's a critical one for both feeding and transmission. That makes it a target.
How would you actually block it? A vaccine?
Possibly. You could vaccinate hosts so their immune systems recognize and attack the protein when a tick injects it. Or you could develop a drug that interferes with the protein's function. The point is, now we know what to aim at.
Does blocking it kill the tick, or just stop disease transmission?
That's the elegant part—it might just stop transmission. The tick might still feed, but the pathogen can't cross over. That's different from pesticides, which kill everything.
Why does that matter?
Because killing all ticks is nearly impossible and has ecological costs. But interrupting one specific biological process? That's surgical. That's something you might actually achieve.